Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism

NCT03988842 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped COVID-19 pandemic

Conditions

Pulmonary Embolism With Acute Cor Pulmonale
Pulmonary Embolism
Pulmonary Embolism With Pulmonary Infarction
Pulmonary Embolism Subacute Massive
Right Ventricular Dysfunction
Right Ventricular Failure

Interventions

DRUG: Alteplase
DRUG: Unfractionated heparin
DRUG: Placebo
DRUG: Apixaban

Sponsor

Victor Tapson, MD

Collaborators

[object Object]